Evaluation of Paracetamol Overdoses in the Pediatric Emergency Department

Ahmet Serkan Ozcan1, Betul Ozturk1, Bilge Akkaya1

  • 1Department of Pediatric Emergency Care, Etlik City Hospital, Ankara, Türkiye.

PubMed

Insights

Most pediatric paracetamol overdoses involve tablets, with intentional ingestions more frequent in adolescent females. Clinical evaluation is crucial for all cases, especially intentional ones, to ensure patient safety.

Area of Science:

  • Pediatric Emergency Medicine
  • Clinical Toxicology
  • Pharmacology

Background:

  • Paracetamol (acetaminophen) is a common analgesic and antipyretic used globally in pediatric populations.
  • Overdose cases present a significant challenge in pediatric emergency departments, necessitating a thorough understanding of patient demographics and outcomes.

Purpose of the Study:

  • To characterize pediatric patients presenting with paracetamol overdose.
  • To evaluate the clinical outcomes and management strategies for these patients.

Main Methods:

  • A retrospective cross-sectional study was conducted on 112 pediatric patients (1 month to 18 years) admitted for paracetamol overdose.
  • Patients were categorized into intentional and unintentional ingestion groups.
  • Data analyzed included patient demographics, ingestion details, serum paracetamol levels, clinical outcomes, and treatment provided.

Main Results:

  • Intentional overdoses (63.4%) were more common in older adolescent females and associated with psychiatric disorders and multidrug ingestions.
  • Tablet formulations were the most frequent form of ingestion (78.6%).
  • Hepatotoxicity and nephrotoxicity were rare and mild; all patients were discharged in stable condition without mortality.

Conclusions:

  • Paracetamol overdose in children often involves tablet formulations, with intentional ingestions predominantly seen in adolescent females.
  • Clinical assessment is vital for all overdose cases, irrespective of the reported intake amount.
  • Prompt and appropriate management, including N-acetylcysteine administration when indicated, leads to favorable outcomes.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
235
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K